Director, Global Medical Evidence Generation Lead, Oncology

The Director of Medical Evidence Generation in Medical Affairs will lead the strategic development and execution of a robust evidence generation plan for an important asset within the Oncology portfolio, focusing on gastrointestinal (GI) and genitourinary (GU) cancers. The role oversees Clinical Research Collaborations (CRCs), Medical Affairs Sponsored Trials (MAST), and Investigator‑Sponsored Research Studies (ISRs), aimed at uncovering new development opportunities and addressing unmet needs.

• Define and drive the integrated evidence generation strategy aligned with Medical Affairs and overall product strategy, spanning clinical trials (Phase II/IV), real‑world evidence, non‑interventional studies, registries, observational research, and health outcomes studies.
• Critically assess the design of research concepts to ensure strategic alignment with BMS priorities and achieve the stated objectives.
• Lead or significantly contribute to protocol development, including study design, objectives and endpoints, eligibility criteria, statistical considerations, and operational feasibility.
• Be accountable for delivering studies from concept ideation to governance approval and through the study lifecycle.
• Serve as a thought leader on evidence generation methodologies to ensure evidence plans are fit‑for‑purpose and impactful.
• Lead preparation and delivery of evidence generation proposals and updates, including results, to internal governance bodies and cross‑functional stakeholders.
• Apply strong understanding of GCP, ICH guidelines, and clinical trial governance to ensure compliant and high‑quality study execution.
• Partner with Clinical Operations and CROs to ensure studies are delivered on time, on budget, and with high data quality.
• Participate in advisory boards, steering committees, and scientific forums as necessary.
• Collaborate with cross‑functional partners to ensure cohesive planning and execution of evidence generation activities across geographies and therapeutic areas.
• Oversee operational delivery of studies, ensuring scientific rigor, quality, compliance (GCP/SOP), timelines, and budgets.
• Contribute to scientific dissemination through publications, abstracts, congress presentations, and advisory boards.
• This position is based at Lawrenceville (PPK) or Madison (GIR) New Jersey.

• Advanced scientific degree (MD, PhD, PharmD, MS or equivalent) with extensive, relevant scientific and/or strong clinical development experience.
• At least 5 years of experience in pharmaceutical clinical development, Medical Affairs, and/or relevant commercial experience; previous customer‑facing role experience highly desirable.
• Deep understanding of clinical research and evidence generation methodologies.
• Deep oncology therapeutic area expertise, with a focus in GI and GU cancers.
• Demonstrated ability to strategically analyze data generation opportunities with minimal supervision and to critically review key study design elements.
• Strategic thinker with strong execution discipline.
• Demonstrated ability to develop and sustain high‑performing, peer relationships with external thought leaders and internal matrix stakeholders.
• Understanding of global healthcare systems and academic settings with a demonstrated ability to lead in ambiguous and changing environments.
• Exceptional communication and interpersonal skills to influence decision‑making at all levels of the organization.
• Proven experience leading cross‑functional study teams and governance interactions.
• Expected 20% global travel.

Madison – Giralda – NJ – US: $207,490 – $251,433 Princeton – NJ – US: $207,490 – $251,433

The starting compensation range(s) for this role are listed above for a full‑time employee (FTE) basis. Additional incentive cash and stock opportunities may be available. Final, individual compensation will be decided based on demonstrated experience.

• Medical, pharmacy, dental, and vision coverage.
• Well‑being support programs:
  Well‑Being Account, Living Life Better, Employee Assistance Programs.
• Financial well‑being and protection: 401(k) plan, disability insurance, life insurance, supplemental health…